Product Information
LYRICA 225 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $9.6730 per EA under NDC 00071101968. Its NADAC has been published 631 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
225 mg/1
Manufacturer
Pfizer Inc.NDC
00071101968
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
New Drug (NDA)
FDA Application
NDA021446On Market Since
12/30/2004
Price Statistics
The NADAC for LYRICA 225 MG CAPSULE has been published 631 times since Nov 28, 2013, and over the history we have for it it has risen 169.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6730 per EA |
|---|---|
| All-time high | $9.7370 (Jul 10, 2024) |
| All-time low | $3.5939 (Nov 28, 2013) |
| 52-week high | $9.7043 |
| 52-week low | $9.6730 |
| Median price | $7.4884 |
| Average price | $7.4261 |
| Largest weekly change | +9.4% (Jan 4, 2017) |
| Weeks tracked | 631 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LYRICA 225 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LYRICA 225 MG CAPSULE, manufactured by Pfizer Inc., is $9.6730 per EA (NDC 00071101968), effective Jun 24, 2026.
How has the price of LYRICA 225 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LYRICA 225 MG CAPSULE has risen 169.1%. It has been tracked across 631 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LYRICA 225 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LYRICA 225 MG CAPSULE has ranged from a low of $3.5939 (Nov 28, 2013) to a high of $9.7370 (Jul 10, 2024), with a median of $7.4884 per EA.
Are there cheaper alternatives to LYRICA 225 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PREGABALIN 225 MG CAPSULE, is $0.0555 per EA — about 99% below LYRICA 225 MG CAPSULE.
Who manufactures LYRICA 225 MG CAPSULE?
LYRICA 225 MG CAPSULE (NDC 00071101968) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification